Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
暂无分享,去创建一个
L. Finelli | N. Cox | T. Uyeki | J. Bresee | D. Shay | A. Fiore | J. Iskander | J. Singleton | P. Wortley | G. Euler | K. Broder
[1] John W. Harris,et al. INFLUENZA OCCURRING IN PREGNANT WOMEN: A STATISTICAL STUDY OF THIRTEEN HUNDRED AND FIFTY CASES , 1919 .
[2] D. Freeman,et al. Deaths from Asian influenza associated with pregnancy. , 1959, American journal of obstetrics and gynecology.
[3] D. E. Rogers,et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.
[4] D. Widelock,et al. Influenza, pregnancy, and fetal outcome. , 1963, Public health reports.
[5] A. Monto,et al. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. , 1970, The Journal of infectious diseases.
[6] S. Shapiro,et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. , 1973, International Journal of Epidemiology.
[7] M. Cooney,et al. A Hong Kong influenza immunity three years after immunization. , 1973, JAMA.
[8] J. Fox,et al. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. , 1975, American journal of epidemiology.
[9] A. Monto,et al. The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. , 1975, American journal of epidemiology.
[10] A. Hampson,et al. Antibody response to one and two doses of influenza virus subunit vaccine. , 1976, The Medical journal of Australia.
[11] H. D. Hochstein,et al. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. , 1976, American journal of epidemiology.
[12] W. Vaughn,et al. Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. , 1977, The Journal of infectious diseases.
[13] W. Dowdle,et al. Swine influenza virus infections in humans. , 1977, The Journal of infectious diseases.
[14] R. Couch,et al. Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.
[15] T. D. Bell,et al. Immunization with killed influenza virus in children with chronic asthma. , 1978, Chest.
[16] S. Schoenbaum,et al. Respiratory infection in pregnancy. , 1979, Clinical obstetrics and gynecology.
[17] J A Bryan,et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.
[18] R. Gibbs,et al. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. , 1979, The Journal of infectious diseases.
[19] C W Potter,et al. Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.
[20] J. Oxford,et al. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection , 1979, Journal of Hygiene.
[21] J. Mullooly,et al. Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.
[22] P. Griffiths,et al. A prospective study of influenza infections during pregnancy. , 1980, Journal of Epidemiology and Community Health.
[23] J. Puck,et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. , 1980, The Journal of infectious diseases.
[24] A. Deinard,et al. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. , 1981, American journal of obstetrics and gynecology.
[25] R. Holman,et al. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. , 1981, The New England journal of medicine.
[26] L. Schonberger,et al. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. , 1982, JAMA.
[27] J. Mullooly,et al. Impact of type A influenza on children: a retrospective study. , 1982, American journal of public health.
[28] J. L. Montagne,et al. Summary of clinical trials of inactivated influenza vaccine - 1978. , 1983, Reviews of infectious diseases.
[29] A. Monto,et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. , 1983, Reviews of infectious diseases.
[30] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.
[31] C. Hall,et al. Influenza A virus infection imitating bacterial sepsis in early infancy , 1984, Pediatric infectious disease.
[32] R. Couch,et al. Sporadic occurrence of zoonotic swine influenza virus infections , 1984, Journal of clinical microbiology.
[33] R. Strunk,et al. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. , 1985, The Journal of pediatrics.
[34] A. Kendal,et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. , 1985, JAMA.
[35] B. Murphy,et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.
[36] W. Barker,et al. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. , 1986, American journal of public health.
[37] A. Kendal,et al. Risk factors for outbreaks of influenza in nursing homes. A case-control study. , 1986, American journal of epidemiology.
[38] J. Mullooly,et al. Risk of acute respiratory disease among pregnant women during influenza A epidemics. , 1986, Public health reports.
[39] V. Baker,et al. Fatal Influenza a Pneumonia in Pregnancy , 1986, American journal of perinatology.
[40] W. P. Glezen,et al. Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.
[41] Update: influenza activity--United States. , 1986, MMWR. Morbidity and mortality weekly report.
[42] W. P. Glezen,et al. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.
[43] R. Douglas,et al. Immunization of elderly people with two doses of influenza vaccine , 1987, Journal of clinical microbiology.
[44] B. L. Beattie,et al. Comparison of one- and two-dose regimens of influenza vaccine for elderly men. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[45] L. Kingsley,et al. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. , 1987, JAMA.
[46] D. Tyrrell. Options for the Control of Influenza , 1987 .
[47] E. Ayoub,et al. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. , 1987, The Pediatric infectious disease journal.
[48] J. Rowe. Report of the Institute of Medicine , 1987 .
[49] R. Carpenter,et al. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. , 1988, The Journal of reproductive medicine.
[50] J. Margolick,et al. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. , 1989, JAMA.
[51] K. Nichol,et al. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. , 1990, JAMA.
[52] W. Raub. From the National Institutes of Health. , 1990, JAMA.
[53] B. L. Beattie,et al. Age‐Related Decline in Interleukin 2 Production in Response to Influenza Vaccine , 1990, Journal of the American Geriatrics Society.
[54] L. Kirkland. Ocular Sensitivity to Thimerosal: A Problem With Hepatitis B Vaccine? , 1990, Southern medical journal.
[55] J. Mills,et al. Influenza in patients with human immunodeficiency virus infection. , 1990, Chest.
[56] W. P. Glezen,et al. Morbidity associated with the major respiratory viruses. , 1990, Pediatric annals.
[57] R. Couch,et al. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. , 1991, The Journal of infectious diseases.
[58] M. Levin,et al. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. , 1991, Pediatrics.
[59] T. Heikkinen,et al. Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.
[60] W. Aberer. Vaccination despite thimerosal sensitivity , 1991, Contact dermatitis.
[61] D. Ho. HIV-1 viraemia and influenza , 1992, The Lancet.
[62] D. Morse,et al. An Outbreak of Influenza A (H3N2) in a Well Immunized Nursing Home Population , 1992, Journal of the American Geriatrics Society.
[63] G. Dinant,et al. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. , 1993, BMJ.
[64] W. P. Glezen,et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. , 1993, The Journal of infectious diseases.
[65] Larry K. Pickering,et al. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[66] K. Edwards,et al. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. , 1994, The Pediatric infectious disease journal.
[67] N. Sugaya,et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. , 1994, JAMA.
[68] G. Dinant,et al. The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .
[69] M. Levin,et al. Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. , 1994, Vaccine.
[70] M. Hornbrook,et al. Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization , 1994, Annals of Internal Medicine.
[71] R. Jonsson,et al. Parenteral influenza vaccination induces a rapid systemic and local immune response. , 1995, The Journal of infectious diseases.
[72] H. Sacks,et al. The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.
[73] K. Nichol,et al. The effectiveness of vaccination against influenza in healthy, working adults. , 1995, The New England journal of medicine.
[74] W. O'brien,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.
[75] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[76] E. Walter,et al. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. , 1995, Archives of Pediatrics & Adolescent Medicine.
[77] J. Flynn,et al. Effective immunization against influenza in pediatric renal transplant recipients. , 1996, Clinical transplantation.
[78] Marie Gauthier,et al. 1994 Red Book: Report of the Committee on Infectious Diseases , 1996 .
[79] A. Frank,et al. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. , 1996, Pediatrics.
[80] J. Margolick,et al. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. , 1996, The Journal of infectious diseases.
[81] K. Nichol,et al. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. , 1996, Archives of internal medicine.
[82] J. Banks,et al. Avian influenza virus isolated from a woman with conjunctivitis , 1996, The Lancet.
[83] B. Breuer,et al. Sequential Outbreak of Influenza A and B in a Nursing Home: Efficacy of Vaccine and Amantadine , 1996, Journal of the American Geriatrics Society.
[84] B. O'Donnell,et al. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993–4 epidemic: results of serum testing and questionnaire , 1996, BMJ.
[85] F. Hayden,et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] Y. Hirota,et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. , 1997, Vaccine.
[87] P. Gross,et al. Time to earliest peak serum antibody response to influenza vaccine in the elderly , 1997, Clinical and diagnostic laboratory immunology.
[88] D. Stott,et al. Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients , 1997, The Journal of infectious diseases.
[89] R B Couch,et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.
[90] E. Ong,et al. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers , 1997, International journal of STD & AIDS.
[91] L. Simonsen,et al. The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.
[92] D. Campbell,et al. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. , 1997, Journal of occupational and environmental medicine.
[93] H. Kessler,et al. Immunologic and virologic evaluation after influenza vaccination of HIV‐1‐infected patients , 1997, AIDS.
[94] R. Kerstens,et al. IMMUNOGENICITY AND TOLERABILITY OF A TRIVALENT INFLUENZA SUBUNIT VACCINE (INFLUVAC®) IN HIGH‐RISK CHILDREN AGED 6 MONTHS TO 4 YEARS , 1997, The British journal of clinical practice.
[95] D. Bernstein,et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. , 1998, The Journal of infectious diseases.
[96] M. Guarino,et al. Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology. , 1998, Neuroepidemiology.
[97] J. Mandel,et al. Absenteeism among employees who participated in a workplace influenza immunization program. , 1998, Journal of occupational and environmental medicine.
[98] H. Sampson,et al. Safe administration of influenza vaccine to patients with egg allergy. , 1998, The Journal of pediatrics.
[99] G. Mckhann,et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome , 1998, Neurology.
[100] F. Hayden,et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.
[101] K. Nichol,et al. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.
[102] L. Magder,et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. , 1998, The New England journal of medicine.
[103] L. Simonsen,et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. , 1998, American journal of epidemiology.
[104] P. Schmitz,et al. The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.
[105] A. Kaplan,et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. , 1998, Vaccine.
[106] Recommendations regarding the use of vaccines that contain thimerosal as a preservative. , 1999, MMWR. Morbidity and mortality weekly report.
[107] B. Ashby-Hughes,et al. Provider endorsement: the strongest cue in prompting high-risk adults to receive influenza and pneumococcal immunizations. , 1999, Clinical excellence for nurse practitioners : the international journal of NPACE.
[108] E. Toy,et al. Influenza Vaccination in Pregnancy , 1999, American journal of perinatology.
[109] R. Betts,et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. , 1999, Vaccine.
[110] A. Haverich,et al. Influenza vaccination in heart transplant recipients. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[111] L. Jackson,et al. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. , 1999, Vaccine.
[112] N. Cox,et al. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[113] R. Couch. Influenza, influenza virus vaccine, and human immunodeficiency virus infection. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[114] K. Neuzil,et al. Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.
[115] A. Monto,et al. Effectiveness of Inactivated Influenza Vaccine Among Nursing Home Residents During an Influenza Type A (H3N2) Epidemic , 1999, Journal of the American Geriatrics Society.
[116] W. Gruber,et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. , 1999 .
[117] M. Peiris,et al. Human infection with influenza H9N2 , 1999, The Lancet.
[118] M. Steinhoff,et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. , 1999, JAMA.
[119] M. Nettleman,et al. Potential Cost Savings Attributable to Influenza Vaccination of School-aged Children , 1999, Pediatrics.
[120] Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. , 1999, JAMA.
[121] S. Salmaso,et al. Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination. , 1999, Vaccine.
[122] Karen McAulay,et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial , 2000, The Lancet.
[123] B. Gonik,et al. The Obstetrician‐Gynecologist's Role in Vaccine‐Preventable Diseases and Immunization , 2000, Obstetrics and gynecology.
[124] K. Neuzil,et al. The burden of influenza illness in children with asthma and other chronic medical conditions. , 2000, The Journal of pediatrics.
[125] Lihan K. Yan,et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. , 2000, The Journal of infectious diseases.
[126] R. Davis,et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.
[127] M. Cetron,et al. Cruise ships: high-risk passengers and the global spread of new influenza viruses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[128] R. Cunney,et al. An Outbreak of Influenza A in a Neonatal Intensive Care Unit , 2000, Infection Control & Hospital Epidemiology.
[129] D. Bratzler,et al. Hospital-Based Influenza and Pneumococcal Vaccination: Sutton's Law Applied to Prevention , 2000, Infection Control & Hospital Epidemiology.
[130] K. K. Lai,et al. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[131] Lihan K. Yan,et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. , 2000, The Journal of infectious diseases.
[132] M. Nettleman,et al. Economic Impact of Influenza Vaccination in Preschool Children , 2000, Pediatrics.
[133] T. Jefferson,et al. Vaccines for preventing influenza in people with asthma. , 2000, The Cochrane database of systematic reviews.
[134] P. Fast,et al. Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial , 2000, Journal of Clinical Microbiology.
[135] E F Mitchel,et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.
[136] J. McElhaney,et al. Standing orders for influenza vaccination increased vaccination rates in inpatient settings compared with community rates. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[137] R. Davis,et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. , 2000, Bulletin of the World Health Organization.
[138] L. Simonsen,et al. The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.
[139] N. Cox,et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. , 2000, JAMA.
[140] Lihan K. Yan,et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. , 2000, The Journal of pediatrics.
[141] P. Sullivan,et al. Effect of influenza vaccination on disease progression among HIV-infected persons , 2000, AIDS.
[142] H. Dibarboure,et al. Safety and immunogenicity of a paediatric presentation of an influenza vaccine , 2000, Archives of disease in childhood.
[143] R. Couch,et al. Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.
[144] R. Haubrich,et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. , 2000, The Journal of infectious diseases.
[145] R. Wood‐Baker,et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.
[146] J. Oxford,et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study , 2000, BJOG : an international journal of obstetrics and gynaecology.
[147] J. D. de Jong,et al. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. , 2000, Vaccine.
[148] W. Gruber,et al. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. , 2000, The Pediatric infectious disease journal.
[149] L. Rodewald,et al. Use of standing orders programs to increase adult vaccination rates. , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[150] An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season. , 2001, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[151] K. Nichol,et al. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. , 2001, Archives of internal medicine.
[152] Robert T. Chen,et al. Does influenza vaccination prevent asthma exacerbations in children? , 2001, The Journal of pediatrics.
[153] G. Dayan,et al. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. , 2001, Vaccine.
[154] D. Ehlert,et al. Influenza vaccination is safe and immunogenic when administered to hospitalized patients. , 2001, Vaccine.
[155] Lihan K. Yan,et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. , 2001, The Pediatric Infectious Disease Journal.
[156] K. Nichol,et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. , 2001, The Journal of infectious diseases.
[157] M. McCormick,et al. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders , 2001 .
[158] W. Dupont,et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience , 2001, The Pediatric infectious disease journal.
[159] A. Monto,et al. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. , 2001, American journal of epidemiology.
[160] K. Nichol,et al. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. , 2001, Archives of internal medicine.
[161] R. M. Hendry,et al. Immune response to influenza vaccine in adult liver transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[162] S. M. Marcy,et al. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. , 2001, The Pediatric infectious disease journal.
[163] Lihan K. Yan,et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. , 2001, Pediatrics.
[164] M. Gaglani,et al. A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease , 2001, The Pediatric infectious disease journal.
[165] C. Bridges,et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[166] E. Tanzi,et al. Influenza vaccination of HIV‐1‐positive and hiv‐1‐negative former intravenous drug users , 2001, Journal of medical virology.
[167] T. Ezzati-Rice,et al. Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates. National Immunization Survey. National Health Interview Survey/National Immunization Provider Record Check Study. , 2001, American journal of preventive medicine.
[168] Yuan-ji Guo,et al. Influenza activity in China: 1998-1999. , 2002, Vaccine.
[169] G. Redding,et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma , 2002, The Pediatric infectious disease journal.
[170] K. Edwards,et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. , 2002, The Journal of infectious diseases.
[171] D. Skowronski,et al. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season. , 2002, Vaccine.
[172] C. Olsen. The emergence of novel swine influenza viruses in North America. , 2002, Virus research.
[173] 马建新,et al. 呼吸机相关性肺炎的非侵入性与侵入性检查 [英]/Ruiz M…//Am J Respir Crit Care Med , 2002 .
[174] R. Zeiger. Current issues with influenza vaccination in egg allergy. , 2002, The Journal of allergy and clinical immunology.
[175] L. Brammer,et al. Serologic Evidence of H1 Swine Influenza Virus Infection in Swine Farm Residents and Employees , 2002, Emerging infectious diseases.
[176] D. Skowronski,et al. Low risk of recurrence of oculorespiratory syndrome following influenza revaccination. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[177] J. Lopreiato,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .
[178] J. Fish,et al. The safety of inactivated influenza vaccine in adults and children with asthma , 2001 .
[179] R. Hughes,et al. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation , 2002, Journal of neurology, neurosurgery, and psychiatry.
[180] K. Nichol,et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[181] Hhs Centers for Medicare Medicare Services. Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Final rule with comment period. , 2002, Federal register.
[182] D. Bratzler,et al. Failure to vaccinate Medicare inpatients: a missed opportunity. , 2002, Archives of internal medicine.
[183] A. Detsky,et al. Use of, Effectiveness of, and Attitudes Regarding Influenza Vaccine Among House Staff , 2003, Infection Control & Hospital Epidemiology.
[184] R. Walker,et al. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. , 2003, Vaccine.
[185] Susanna Esposito,et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. , 2003, Vaccine.
[186] Robert L Davis,et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.
[187] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[188] M. Fine,et al. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. , 2003, Vaccine.
[189] L. Sehulster,et al. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[190] D. Skowronski,et al. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[191] Lihan K. Yan,et al. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children , 2003, The Pediatric infectious disease journal.
[192] J. Treanor,et al. Immune correlates of protection against influenza in the human challenge model. , 2003, Developments in biologicals.
[193] R. Dittus,et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. , 2003, American journal of obstetrics and gynecology.
[194] M. Cetron,et al. Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[195] R. Davis,et al. Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.
[196] K. Nichol,et al. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. , 2003, Vaccine.
[197] Robert T. Chen,et al. Guillain-Barré syndrome following influenza vaccination , 2004, Reactions Weekly.
[198] Robert L Davis,et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. , 2004, Archives of pediatrics & adolescent medicine.
[199] R. Walker,et al. Measuring Antibody Responses to a Live Attenuated Influenza Vaccine in Children , 2004, The Pediatric infectious disease journal.
[200] Theresa E. Fuller,et al. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons. , 2004, Archives of internal medicine.
[201] E. Lewis,et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents , 2004, The Pediatric infectious disease journal.
[202] E. Gurfinkel,et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. , 2004, European heart journal.
[203] Benjamin Schwartz,et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. , 2004, Pediatrics.
[204] M. Halloran,et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. , 2004, Archives of pediatrics & adolescent medicine.
[205] J. Gerberding,et al. Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. , 2004, MMWR. Morbidity and mortality weekly report.
[206] R. Belshe,et al. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination , 2004, The Pediatric infectious disease journal.
[207] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[208] S. Black,et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. , 2004, American journal of perinatology.
[209] F. Hayden,et al. Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians , 2004, Infection Control & Hospital Epidemiology.
[210] W. Dejsomritrutai,et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. , 2004, Chest.
[211] A. Branch,et al. Influenza Vaccination in Orthotopic Liver Transplant Recipients: Absence of Post Administration ALT Elevation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[212] D. Krysan. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. , 2004, The Journal of pediatrics.
[213] N. Cox,et al. Reassortment and evolution of current human influenza A and B viruses. , 2004, Virus research.
[214] R. Walker,et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[215] M. Moss. RISK OF ANAPHYLAXIS AFTER VACCINATION OF CHILDREN AND ADOLESCENTS , 2004, Pediatrics.
[216] A. Osterhaus,et al. For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .
[217] Marion Koopmans,et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[218] J. Stoddard,et al. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine , 2004, Expert review of vaccines.
[219] E. Rosenberg,et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[220] T. Lieu,et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. , 2004, Pediatrics.
[221] Ray Higginson,et al. The threat of an avian influenza pandemic. , 2005, British journal of nursing.
[222] Interventions to increase influenza vaccination of health-care workers--California and Minnesota. , 2005, MMWR. Morbidity and mortality weekly report.
[223] Pedro A Piedra,et al. Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial , 2005, Pediatrics.
[224] D. Grobbee,et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. , 2005, Archives of internal medicine.
[225] J. Raphaël,et al. [Guillain-Barré syndrome]. , 2005, La Revue du praticien.
[226] Bruce A. Ong,et al. DOES INFLUENZA VACCINATION IMPROVE PEDIATRIC ASTHMA OUTCOMES , 2005 .
[227] K. Edwards,et al. Increasing Rates of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Healthy Children , 2005, The Pediatric infectious disease journal.
[228] M. Nowalk,et al. Parental perspectives on influenza immunization of children aged 6 to 23 months. , 2005, American journal of preventive medicine.
[229] Cecile Viboud,et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.
[230] Susan S Ellenberg,et al. Evaluating the safety of new vaccines: summary of a workshop. , 2005, American journal of public health.
[231] J. McElhaney,et al. The unmet need in the elderly: designing new influenza vaccines for older adults. , 2005, Vaccine.
[232] D. Hopkins,et al. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[233] S. Cosgrove,et al. Influenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine Shortages , 2005, Infection Control & Hospital Epidemiology.
[234] Robert Ball,et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. , 2005, JAMA.
[235] P. Briss,et al. Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. , 2005, American journal of preventive medicine.
[236] R. Stefanacci. Creating artificial barriers to vaccinations. , 2005, Journal of the American Medical Directors Association.
[237] Keiji Fukuda,et al. Influenza-associated deaths among children in the United States, 2003-2004. , 2005, The New England journal of medicine.
[238] K. W. Harris,et al. The Guide to Community Preventive Services , 2005 .
[239] A. Kaira,et al. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly , 2005, Epidemiology and Infection.
[240] S. Rosenbaum,et al. The epidemiology of u.s. immunization law: immunization requirements for staff and residents of long-term care facilities under state laws/regulations. , 2005 .
[241] V Demicheli,et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review , 2005, The Lancet.
[242] R. Keren,et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. , 2005, JAMA.
[243] A. Monto,et al. A Comparison of 2 Influenza Vaccine Schedules in 6- to 23-Month-Old Children , 2005, Pediatrics.
[244] M. Kolczak,et al. Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.
[245] Hhs Centers for Medicare Medicare Services. Medicare and Medicaid programs; condition of participation: immunization standard for long term care facilities. Final rule. , 2005, Federal register.
[246] R. Jacobson,et al. Requiring influenza vaccination for health care workers: seven truths we must accept. , 2005, Vaccine.
[247] John Painter,et al. Effect of handwashing on child health: a randomised controlled trial , 2005, The Lancet.
[248] M. Meltzer,et al. An economic analysis of annual influenza vaccination of children. , 2005, Vaccine.
[249] M. Meltzer,et al. Estimating medical practice expenses from administering adult influenza vaccinations. , 2005, Vaccine.
[250] Pedro A Piedra,et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. , 2005, Vaccine.
[251] R. Kane,et al. The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries. , 2005, Health services research.
[252] R. Saito,et al. Antibody Response to Influenza Vaccination in Nursing Home Residents and Healthcare Workers During Four Successive Seasons in Niigata, Japan , 2005, Infection Control & Hospital Epidemiology.
[253] K. Edwards,et al. Infection Control and Hospital Epidemiology Duration of Virus Shedding after Trivalent Intranasal Live Attenuated Influenza Vaccination in Adults , 2022 .
[254] Peter Szilagyi,et al. Patient reminder and patient recall systems to improve immunization rates. , 2005, The Cochrane database of systematic reviews.
[255] Giovanni Apolone,et al. Influenza vaccine in healthy children: a meta-analysis. , 2005, Vaccine.
[256] A. Hay,et al. Influenza virus infection in travelers to tropical and subtropical countries. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[257] A. Monto,et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. , 2006, The New England journal of medicine.
[258] P. Wortley,et al. Factors Associated with Vaccination of Medicare Beneficiaries in Five U.S. Communities: Results from the Racial and Ethnic Adult Disparities in Immunization Initiative Survey, 2003 , 2006, Journal of the American Geriatrics Society.
[259] L. Solberg,et al. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. , 2006, American journal of preventive medicine.
[260] C. Glaser,et al. Severe Pediatric Influenza in California, 2003–2005: Implications for Immunization Recommendations , 2006, Pediatrics.
[261] K. Nichol. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. , 2006, Vaccine.
[262] B. Psaty,et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. , 2006, International journal of epidemiology.
[263] M. Sidhu,et al. Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. , 2006, Virology.
[264] A. Naleway,et al. Delivering influenza vaccine to pregnant women. , 2006, Epidemiologic reviews.
[265] R. Keren,et al. Direct Medical Cost of Influenza-Related Hospitalizations in Children , 2006, Pediatrics.
[266] Thomas V Inglesby,et al. Disease mitigation measures in the control of pandemic influenza. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.
[267] A. Monto,et al. Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers , 2006, Pediatrics.
[268] T. Jefferson,et al. Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. , 2006, The Lancet. Infectious diseases.
[269] R. Couch,et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. , 2006, Archives of internal medicine.
[270] Robert L Davis,et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. , 2006, JAMA.
[271] New infection control requirement for offering influenza vaccination to staff and licensed independent practitioners. , 2006, Joint Commission perspectives. Joint Commission on Accreditation of Healthcare Organizations.
[272] S. Cox,et al. Hospitalizations With Respiratory Illness Among Pregnant Women During Influenza Season , 2006, Obstetrics and gynecology.
[273] U. Wahn,et al. Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma , 2006, The Pediatric infectious disease journal.
[274] J. McCullers,et al. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. , 2006, The Journal of infectious diseases.
[275] E. Thacker,et al. Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[276] Harlan M Krumholz,et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. , 2006, Journal of the American College of Cardiology.
[277] W. Gruber,et al. Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.
[278] Cécile Viboud,et al. Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.
[279] K. Nichol,et al. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. , 2006, Vaccine.
[280] W. Hanshaoworakul,et al. Investigation of avian influenza (H5N1) outbreak in humans--Thailand, 2004. , 2006, MMWR supplements.
[281] W. Schaffner,et al. Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 , 2006, The Pediatric infectious disease journal.
[282] A. Oner,et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. , 2006, The New England journal of medicine.
[283] C. Byington,et al. Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection , 2006, Pediatrics.
[284] A. Monto,et al. Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming? , 2005, Pediatrics.
[285] K. Nichol,et al. Do recommended high-risk adults benefit from a first influenza vaccination? , 2006, Vaccine.
[286] A. Gilsdorf,et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[287] D. Fleming,et al. Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care , 2006, Pediatrics.
[288] Lawrence O Gostin,et al. Medical countermeasures for pandemic influenza: ethics and the law. , 2006, JAMA.
[289] J. Nguyen-Van-Tam,et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[290] C. Bridges,et al. Influenza Vaccination of Health-Care Personnel Recommendations of the Healthcare Infection Control Practices Advisory Committee ( HICPAC ) and the Advisory Committee on Immunization Practices ( ACIP ) , 2006 .
[291] T. Lieu,et al. Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children , 2006, Emerging infectious diseases.
[292] N. Brewer,et al. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[293] C. Bridges,et al. The underrecognized burden of influenza in young children. , 2006, The New England journal of medicine.
[294] A. Razmpour,et al. A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine , 2006, The Pediatric infectious disease journal.
[295] N. Cox,et al. Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model , 2006, Proceedings of the National Academy of Sciences.
[296] T. Lieu,et al. Parental Perspectives on Influenza Vaccination among Children with Asthma , 2006, Public health reports.
[297] Mandy A. Allison,et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. , 2006, The Journal of pediatrics.
[298] S. Black,et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. , 2006, Archives of pediatrics & adolescent medicine.
[299] Ross E. G. Upshur,et al. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. , 2006, Archives of internal medicine.
[300] Mark A. Miller,et al. US flu mortality estimates are based on solid science , 2006, BMJ : British Medical Journal.
[301] K. Nichol,et al. Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.
[302] C. Bridges,et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. , 2006, The Journal of infectious diseases.
[303] Florence T. Bourgeois,et al. Influenza and Other Respiratory Virus–Related Emergency Department Visits Among Young Children , 2006, Pediatrics.
[304] N. Tien,et al. Risk Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004 , 2006, Emerging infectious diseases.
[305] J. Nelson,et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. , 2006, International journal of epidemiology.
[306] P. Horby,et al. Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.
[307] Yi Guan,et al. Three Indonesian clusters of H5N1 virus infection in 2005. , 2006, The New England journal of medicine.
[308] Anne M Johnson,et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial , 2006, BMJ : British Medical Journal.
[309] Gregory C Gray,et al. Cases of swine influenza in humans: a review of the literature. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[310] K. Fiscella,et al. Impact of influenza vaccination disparities on elderly mortality in the United States. , 2007, Preventive medicine.
[311] Collective Editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[312] R. Davis,et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. , 2007, The New England journal of medicine.
[313] K. Nichol,et al. Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.
[314] T. Jefferson,et al. Influenza vaccination for elderly people and their care workers , 2007, The Lancet.
[315] R. Webby,et al. Identification of H2N3 influenza A viruses from swine in the United States , 2007, Proceedings of the National Academy of Sciences.
[316] I. Petersen,et al. Guillain-Barré Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database , 2007, PloS one.
[317] Ivan S F Chan,et al. Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older , 2007, Journal of the American Geriatrics Society.
[318] M. Irigoyen,et al. Influenza Vaccine Coverage and Missed Opportunities Among Inner-city Children Aged 6 to 23 Months: 2000-2005 , 2007, Pediatrics.
[319] W. P. Glezen,et al. Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003–2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children , 2007, Pediatrics.
[320] W. Schaffner,et al. Mass Distribution of Free, Intranasally Administered Influenza Vaccine in a Public School System , 2007, Pediatrics.
[321] L. Dodds,et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women , 2007, Canadian Medical Association Journal.
[322] T. Jefferson,et al. Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses , 2008, Evidence-based child health : a Cochrane review journal.
[323] Influenza vaccination coverage among children with asthma--United States, 2004-05 influenza season. , 2007, MMWR. Morbidity and mortality weekly report.
[324] C. Bridges,et al. Influenza- and RSV-associated hospitalizations among adults. , 2007, Vaccine.
[325] Farzad Mostashari,et al. Monitoring the Impact of Influenza by Age: Emergency Department Fever and Respiratory Complaint Surveillance in New York City , 2007, PLoS medicine.
[326] R. Walker,et al. Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.
[327] A. Razmpour,et al. Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia , 2007, The Pediatric infectious disease journal.
[328] R. Baltimore,et al. Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006–2007 , 2007, Pediatrics.
[329] C. Bridges,et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.
[330] J. Raboud,et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[331] C. Bridges,et al. Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004 , 2007, Pediatrics.
[332] F. Shaw,et al. Assessing state immunization requirements for healthcare workers and patients. , 2007, American journal of preventive medicine.
[333] S. Dreskin,et al. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[334] D. Snydman. Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006 , 2007 .
[335] R. Keren,et al. Incidence, Complications, and Risk Factors for Prolonged Stay in Children Hospitalized With Community-Acquired Influenza , 2007, Pediatrics.
[336] C. Bridges,et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. , 2007, Vaccine.
[337] Cecile Viboud,et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.
[338] Mph Dr. Kristin L. Nichol MD,et al. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults , 2007, Journal of General Internal Medicine.
[339] Jan Bonhoeffer,et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. , 2007, Vaccine.
[340] Robert J. Taylor,et al. Effectiveness of influenza vaccination. , 2007, The New England journal of medicine.
[341] A. Capuano,et al. Swine Workers and Swine Influenza Virus Infections , 2007, Emerging infectious diseases.
[342] R. Couch,et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. , 2007, Vaccine.
[343] D. Christakis,et al. Hospital-Based Influenza Vaccination of Children: An Opportunity to Prevent Subsequent Hospitalization , 2008, Pediatrics.
[344] Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. , 2008, Releve epidemiologique hebdomadaire.
[345] Lihan K. Yan,et al. Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines , 2008, Pediatrics.
[346] D. Skowronski,et al. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? , 2008, The Journal of infectious diseases.
[347] James A Singleton,et al. Influenza vaccination of recommended adult populations, U.S., 1989-2005. , 2008, Vaccine.
[348] J. Gerberding,et al. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. , 2008, MMWR. Morbidity and mortality weekly report.
[349] C. Bridges,et al. Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003–2004 and 2004–2005 Influenza Seasons , 2008, Pediatrics.
[350] A. Kumar,et al. Three Indonesian Clusters of H5N1 Virus Infection in 2005 , 2008 .
[351] W. P. Glezen,et al. Safety of the Intranasal, Trivalent, Live Attenuated Influenza Vaccine (LAIV) in Children With Intermittent Wheezing in an Open-Label Field Trial , 2008, The Pediatric infectious disease journal.
[352] J. Farrar,et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series , 2008, The Lancet.
[353] B. Stricker,et al. Mortality benefits of influenza vaccination in elderly people. , 2008, The Lancet. Infectious diseases.
[354] K. Poehling,et al. Influenza Burden for Children With Asthma , 2008, Pediatrics.
[355] P. Mangtani,et al. Influenza vaccination in pregnancy: current evidence and selected national policies. , 2008, The Lancet. Infectious diseases.
[356] D. Bernstein,et al. Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age , 2008, Pediatrics.
[357] J. Cavanaugh,et al. Relationship of Influenza Vaccination Declination Statements and Influenza Vaccination Rates for Healthcare Workers in 22 US Hospitals , 2008, Infection Control & Hospital Epidemiology.
[358] Influenza activity--United States and worldwide, 2007-08 season. , 2008, MMWR. Morbidity and mortality weekly report.
[359] M. Braun,et al. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. , 2008, Vaccine.
[360] T. Beebe,et al. Influenza Vaccination Among Registered Nurses: Information Receipt, Knowledge, and Decision-Making at an Institution With a Multifaceted Educational Program , 2008, Infection Control & Hospital Epidemiology.
[361] A. Osterhaus,et al. Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[362] A. Monto,et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. , 2008, The Journal of infectious diseases.
[363] J. Cavanaugh,et al. Elements of influenza vaccination programs that predict higher vaccination rates: results of an emerging infections network survey. , 2008, Clinical Infectious Diseases.
[364] Cathleen K. Yoshida,et al. Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. , 2008, American journal of obstetrics and gynecology.
[365] A. Lackenby,et al. The potential impact of neuraminidase inhibitor resistant influenza , 2008, Current opinion in infectious diseases.
[366] C. Kȩpka,et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. , 2008, European heart journal.
[367] J. P. Davis,et al. Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin , 2008, Emerging infectious diseases.
[368] Zhongjie Li,et al. Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China , 2008, PLoS ONE.
[369] A. Fernández-Sesma,et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[370] Colin A. Russell,et al. The Global Circulation of Seasonal Influenza A (H3N2) Viruses , 2008, Science.
[371] C. Dekker,et al. An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines , 2008, Pediatrics.
[372] Ross Upshur,et al. The Effect of Universal Influenza Immunization on Mortality and Health Care Use , 2008, PLoS medicine.
[373] F. Hayden,et al. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. , 2008, Vaccine.
[374] Cécile Viboud,et al. Multiple Reassortment Events in the Evolutionary History of H1N1 Influenza A Virus Since 1918 , 2008, PLoS pathogens.
[375] L. Magder,et al. Countywide School-Based Influenza Immunization: Direct and Indirect Impact on Student Absenteeism , 2008, Pediatrics.
[376] Yu Wang,et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China , 2008, The Lancet.
[377] J. Stockman. Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old , 2008 .
[378] R. Belshe,et al. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. , 2008, Vaccine.
[379] Ron A M Fouchier,et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.
[380] I. Barr,et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[381] T. Uyeki,et al. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[382] P. Barboza,et al. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[383] Lyn Finelli,et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. , 2009, The New England journal of medicine.
[384] K. Edwards,et al. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. , 2009, Vaccine.
[385] R. Heine,et al. Egg allergy in childhood: an update , 2009, Current opinion in allergy and clinical immunology.
[386] Md. Mahmudur Rahman,et al. Avian Influenza Virus A (H5N1), Detected through Routine Surveillance, in Child, Bangladesh , 2009, Emerging infectious diseases.
[387] F. Carrat,et al. Effect of Influenza Vaccination of Nursing Home Staff on Mortality of Residents: A Cluster‐Randomized Trial , 2009, Journal of the American Geriatrics Society.
[388] Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. , 2009, Emerging infectious diseases.
[389] D. Fleming,et al. Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[390] M. Biggerstaff,et al. H1N1 2009 influenza virus infection during pregnancy in the USA , 2009, The Lancet.
[391] Mandy A. Allison,et al. High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage. , 2009, Archives of pediatrics & adolescent medicine.
[392] A. Falsey,et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. , 2009, The Journal of infectious diseases.
[393] Jean A. Roayaei,et al. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. , 2009, JAMA.
[394] A. Schuchat. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[395] L. Finelli,et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.
[396] M. McDonald,et al. Protection of racial/ethnic minority populations during an influenza pandemic. , 2009, American journal of public health.
[397] A. Shane. Effectiveness of Maternal Influenza Immunization in Mothers and Infants , 2009 .
[398] Ross Upshur,et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[399] A. Monto,et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. , 2009, The New England journal of medicine.
[400] Lynnette Brammer,et al. Estimates of US influenza‐associated deaths made using four different methods , 2009, Influenza and other respiratory viruses.
[401] S. Lapinsky,et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.
[402] A. Monto,et al. Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. , 2009, Vaccine.
[403] Tanja Popovic,et al. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[404] M. Halloran,et al. Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States , 2009, American journal of epidemiology.
[405] A. Fiore,et al. Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.
[406] N. Khardori,et al. Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 , 2009 .
[407] A. Mack,et al. Continuing Increases in Autism Reported to California’s Developmental Services System: Mercury in Retrograde , 2009 .
[408] L. Balluz,et al. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[409] D. Vugia,et al. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[410] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[411] A. Fiore,et al. Influenza vaccination coverage among children aged 6-23 months - United States, 2007-08 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.
[412] N. Andrews,et al. Original Contribution Investigation of the Temporal Association of Guillain-Barré Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database , 2009 .
[413] M. Meade,et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.
[414] Gerry Barber,et al. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[415] C. del Rio,et al. Safety of influenza vaccination during pregnancy. , 2009, American journal of obstetrics and gynecology.
[416] C. Bridges,et al. Death and serious illness following influenza vaccination: a multidisciplinary investigation , 2009, Pharmacoepidemiology and drug safety.
[417] Stefan Gravenstein,et al. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[418] A. Stewart. Mandatory vaccination of health care workers. , 2009, The New England journal of medicine.
[419] C. Bridges,et al. Estimating influenza-associated deaths in the United States. , 2009, American journal of public health.
[420] R. Porcher,et al. Guillain-Barré syndrome and influenza virus infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[421] C. Weinbaum,et al. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[422] Simon Cauchemez,et al. CME ACTIVITY: Face Mask Use and Control of Respiratory Virus Transmission in Households , 2009, Emerging infectious diseases.
[423] Bruce A. Ong,et al. Does Influenza Vaccination Improve Pediatric Asthma Outcomes? , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.
[424] C. Fraser,et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. , 2009, The New England journal of medicine.
[425] C. Reed,et al. Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children , 2009, The Pediatric infectious disease journal.
[426] Robert Schechter,et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.
[427] S. Salmaso,et al. Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines , 2009, Pediatrics.
[428] Wang Guansong,et al. Update on avian influenza A (H5N1) virus infection in humans , 2009 .
[429] C. Reed,et al. Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[430] L. Balluz,et al. Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.
[431] R. Bryan,et al. Pandemic influenza preparedness and vulnerable populations in tribal communities. , 2009, American journal of public health.
[432] G. Euler,et al. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey. , 2009, American journal of preventive medicine.
[433] Abstr Act,et al. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand , 2009 .
[434] S. Humiston,et al. Cost of Universal Influenza Vaccination of Children in Pediatric Practices , 2009, Pediatrics.
[435] C. Wichems,et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. , 2009, The New England journal of medicine.
[436] D. Burwen,et al. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. , 2009, Vaccine.
[437] S. Arifeen,et al. Influenza immunization in pregnancy--antibody responses in mothers and infants. , 2010, The New England journal of medicine.
[438] E. Tuomanen,et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. , 2010, The New England journal of medicine.
[439] N. Andrews,et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.
[440] C. Bauch,et al. Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis , 2010, PLoS medicine.
[441] Chih-Jen Wei,et al. Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.
[442] M. Eichelberger,et al. Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host. , 2010, The Journal of infectious diseases.
[443] V. Fraser,et al. Influenza Vaccination among Healthcare Workers: Ten-Year Experience of a Large Healthcare Organization , 2010, Infection Control & Hospital Epidemiology.
[444] S. Bezerra,et al. Lung pathology in fatal novel human influenza A (H1N1) infection. , 2010, American journal of respiratory and critical care medicine.
[445] Atlanta,et al. Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[446] Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[447] Karen Ekernas,et al. Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households: A Cluster Randomized Trial , 2010 .
[448] F. Polack,et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. , 2010, The New England journal of medicine.
[449] A. Kallen,et al. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009. , 2010, MMWR. Morbidity and mortality weekly report.
[450] Benjamin J Cowling,et al. Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. , 2010, American journal of infection control.
[451] Steve Doucette,et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection , 2010, Canadian Medical Association Journal.
[452] Craig M. Hales,et al. Influenza immunization coverage among residents of long-term care facilities certified by CMS, 2005-2006: the newest MDs quality indicator. , 2010, Journal of the American Medical Directors Association.
[453] Y Zhou,et al. Face masks to prevent transmission of influenza virus: a systematic review , 2010, Epidemiology and Infection.
[454] L. Balluz,et al. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009. , 2010, MMWR. Morbidity and mortality weekly report.
[455] J. Stockman. Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection , 2010 .
[456] W. Callaghan,et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. , 2010, JAMA.
[457] L. Brammer,et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[458] M. Blatter,et al. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials , 2010, The Lancet.
[459] P. Horby,et al. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. , 2010, The New England journal of medicine.
[460] Allison E Aiello,et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. , 2010, The Journal of infectious diseases.
[461] T. Santibanez,et al. Behavior and beliefs about influenza vaccine among adults aged 50-64 years. , 2010, American journal of health behavior.
[462] Ruihua Yin,et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. , 2010, American journal of epidemiology.
[463] P. Effler,et al. Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA , 2010, Emerging infectious diseases.
[464] S. Schrag,et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. , 2010, The Journal of infectious diseases.
[465] Update on human cases of highly pathogenic avian influenza A (H5N1) infection: 2009. , 2010, Releve epidemiologique hebdomadaire.
[466] W. Parmet. Pandemic vaccines--the legal landscape. , 2010, The New England journal of medicine.
[467] J. Tokars,et al. H1N1 vaccine safety monitoring: beyond background rates , 2010, The Lancet.
[468] L. Finelli,et al. Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women , 2010, Obstetrics and gynecology.
[469] A. Fowlkes,et al. Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease , 2010, PloS one.
[470] M. Honein,et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. , 2010, The New England journal of medicine.
[471] Atlanta,et al. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. , 2010, MMWR. Morbidity and mortality weekly report.
[472] J. Sejvar,et al. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. , 2010, MMWR. Morbidity and mortality weekly report.
[473] A. Arguedas,et al. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. , 2010, The New England journal of medicine.
[474] W. C. Dunagan,et al. Mandatory influenza vaccination of health care workers: translating policy to practice. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[475] Tom Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[476] D. Earn,et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. , 2010, JAMA.
[477] J. McVernon,et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. , 2010, JAMA.
[478] P. Valdez,et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. , 2010, American journal of respiratory and critical care medicine.
[479] L. Balluz,et al. Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[480] A. Pavia. Mandate to protect patients from health care-associated influenza. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[481] Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. , 2010, MMWR. Morbidity and mortality weekly report.
[482] W. Choi,et al. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. , 2010, Vaccine.
[483] H. A. Cook,et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[484] S. Black,et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines , 2009, The Lancet.
[485] Víctor Hugo Borja-Aburto,et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis , 2009, The Lancet.
[486] Mark A. Miller,et al. Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons , 2010, PLoS currents.
[487] Jeannine S. Schiller,et al. Early release of selected estimates based on data from the January-March 2011 National Health Interview Survey , 2011 .
[488] J. McCullers,et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. , 2011, Vaccine.
[489] T. Jefferson,et al. Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.
[490] Recommended Adult Immunization Schedule: United States, 2012* , 2012, Annals of Internal Medicine.
[491] S. Esposito,et al. Live attenuated intranasal influenza vaccine , 2012, Human vaccines & immunotherapeutics.
[492] T. Lieu,et al. Non-Traditional Settings for Influenza Vaccination of Adults , 2012, PharmacoEconomics.